COVID-19: FDA authorizes second booster for vulnerable groups
The U.S. Food and Drug Administration (FDA) on Tuesday, authorized a second booster dose of either the Pfizer-BioNTech or the Moderna COVID-19 vaccines for older people and certain immunocompromised individuals.
According to the FDA, “A…